Niacinamide in Skincare — Clinical Evidence, Mechanisms of Action, and Why It Is the Most Versatile Active in Skincare Formulation
The Multitasking Vitamin B3 Active — Clinical Evidence, Mechanisms, and Formulation Science. The Science Behind EVIK™ LyoPearl Niacinamide.
Niacinamide — also known as nicotinamide, or vitamin B3 — is one of the most thoroughly researched and widely used actives in skincare. Unlike many single-benefit actives, niacinamide addresses multiple skin concerns simultaneously: it strengthens the barrier, reduces pigmentation, improves signs of photoaging, regulates sebum, and is tolerated by sensitive skin types that cannot tolerate retinol, high-concentration ascorbic acid, or exfoliants. A 2024 comprehensive review characterised it as 'the multitasking marvel for glowing skin' and a 2024 dermal delivery review in Drug Delivery and Translational Research confirmed its established role across brightening, anti-ageing, and barrier protection. Its safety profile, formulation compatibility, and breadth of clinical evidence make it the most broadly applicable active in contemporary skincare formulation. This page covers the evidence behind niacinamide's key mechanisms, its clinical applications in skincare, and why the EVIK™ LyoPearl freeze-dried bead format delivers a pure, precisely dosed, preservative-free form of this active for formulation evaluation.
Looking for the product specification, formula, and sample request? → Go to the EVIK™ LyoPearl Niacinamide product page
What the Clinical Evidence Shows — Five Key MechanismsNiacinamide in Skincare — Clinical Evidence, Mechanisms of Action, and Why It Is the Most Versatile Active in Skincare Formulation
Body text, based on peer-reviewed literature 2021–2024:
Clinical studies consistently show significant improvements in multiple skin parameters with topical niacinamide at concentrations of 2–5%. Comprehensive reviews across literature from 1995 to 2024 identify five primary mechanisms of action:
1. Skin barrier enhancement and ceramide synthesis
Niacinamide is a precursor to NADH and NADPH — coenzymes that serve as cofactors for the synthesis of ceramides, fatty acids, and other critical components of the epidermal lipid barrier. Topical application of niacinamide increases ceramide production, keratin, involucrin, and filaggrin — proteins essential to cornified envelope formation and barrier integrity. Clinical studies have demonstrated measurable reductions in transepidermal water loss (TEWL) and improvements in barrier function with topical niacinamide, with the additional benefit of reducing skin sensitivity to irritating surfactants and improving the tolerability of co-applied ingredients such as retinoids. (Bissett et al., Cosmeceuticals and Active Cosmetics, 2005; Dermatology Times review, 2024.)
2. Skin brightening and inhibition of melanosome transfer
Niacinamide inhibits the transfer of melanosomes from melanocytes to keratinocytes, which is the final step in the process by which pigmentation becomes visible at the skin surface. Crucially, it does not inhibit tyrosinase (the melanin synthesis enzyme) directly, meaning it does not share the irritation potential of some other brightening agents. Clinical studies have demonstrated measurable reductions in hyperpigmentation, sallowness (skin yellowing), and uneven skin tone with topical niacinamide. A 14-week double-blind split-face randomised controlled trial published in the Journal of the American Academy of Dermatology demonstrated significant reduction in facial skin sallowness with niacinamide versus placebo. (Bissett et al., JAAD, 2005; Boo, Antioxidants, 2021; Cosmoderma review, 2025.)
3. Anti-aging and photoaging improvement
Niacinamide restores the cellular NAD+ pool, which declines with chronological ageing and UV exposure. Restored NAD+ supports mitochondrial energetics, reduces oxidative stress, and attenuates the inflammatory signalling that contributes to collagen degradation and structural ageing. Clinical studies using 5% topical niacinamide have demonstrated improvements in fine lines, wrinkles, skin texture, and the appearance of photoaged skin. A comprehensive 2024 review of literature from 1995 to 2024 confirmed multifaceted anti-ageing effects including enhanced collagen synthesis, improved barrier function, reduced hyperpigmentation, and protection against oxidative stress. (Boo, Antioxidants, 2021; Plants Journal anti-ageing review, 2024.)
4. Sebum regulation and pore appearance
Topical niacinamide reduces sebum excretion rate, which contributes to improvements in skin oiliness and the appearance of enlarged pores. This makes it uniquely suited for acne-prone and combination skin types where sebum control is a formulation objective alongside anti-aging or brightening benefits. Niacinamide is one of the few actives with strong evidence for both anti-aging and sebum-regulating benefits in the same concentration range, making it highly versatile in multi-concern formulations. (Ong & Goh, Drug Delivery and Translational Research, 2024.)
5. Anti-inflammatory activity and tolerance enhancement
Niacinamide is a potent inhibitor of proinflammatory cytokines and has demonstrated anti-inflammatory effects relevant to conditions including dermatitis, rosacea, and post-procedure recovery. Its anti-inflammatory profile contributes to its well-documented ability to reduce skin redness, blotchiness, and irritation. Unlike many high-efficacy actives, niacinamide is non-irritating at standard use concentrations and has been used to improve the tolerability of potentially irritating ingredients (retinoids, alpha-hydroxy acids, ascorbic acid) when co-applied. (Ungerstedt et al., Clinical & Experimental Immunology, 2003; Ong & Goh, 2024.)
Formulation Compatibility — Why Niacinamide Works With Almost Everything
One of niacinamide's most practically valuable properties is its exceptional formulation compatibility. Unlike ascorbic acid, which has narrow pH requirements and degrades rapidly in combination with many ingredients, niacinamide is stable across a wide pH range (pH 3–8), compatible with most common skincare actives and excipients, and does not require antioxidant stabilisation. It can be co-formulated with:• Hyaluronic acid — complementary multi-benefit: hydration + barrier support + brightening.• Peptides — no incompatibility; niacinamide's anti-inflammatory activity may enhance peptide-mediated collagen support.• Retinoids — niacinamide reduces retinoid-associated irritation, making it a recommended co-ingredient in retinol formulations.• Ascorbic acid — historically considered incompatible at high concentrations due to formation of nicotinic acid at low pH; at typical use concentrations (under 10% niacinamide, standard serum pH) this is not clinically significant for most formulations.• AHAs and BHAs — niacinamide's barrier-strengthening activity can counterbalance exfoliant-induced barrier disruption.This compatibility makes the EVIK™ LyoPearl Niacinamide bead particularly useful for multi-ingredient evaluation: dissolving the pure bead into a carrier that already contains other actives allows assessment of niacinamide's additive contribution without introducing formulation variables.Skincare Use Cases and Formulation Applications
For skincare brands, formulators, and product developers, EVIK™ LyoPearl Niacinamide supports the following formulation and evaluation contexts:• Multi-benefit serum development — a single niacinamide bead addresses barrier, brightening, anti-aging, and sebum concerns simultaneously; evaluation in a single active before building a multi-ingredient formula.• Brightening and pigmentation treatment formats — precise dosing of niacinamide for spot brightening or full-face hyperpigmentation evaluation.• Retinol tolerance enhancement — dissolve niacinamide bead alongside a retinol serum to evaluate its reported tolerance-improvement effect.• Barrier repair formulation evaluation — assessment of niacinamide's ceramide-boosting and TEWL-reducing activity in compromised or sensitive skin formulations.• Sebum and pore formulation — evaluation in oily, acne-prone, and combination skin product lines where niacinamide's dual anti-aging and sebum-regulating activity is relevant.• Ingredient compatibility studies — pure niacinamide bead dissolved into existing formulations to assess compatibility, interaction, and additive efficacy contribution.• Preservative-free multi-active systems — single-dose bead format enables evaluation of niacinamide delivery without preservative system, for clean-beauty and free-from product development.A Note on Concentration and Dissolution
Clinical studies demonstrating niacinamide's efficacy have used topical concentrations of 2–5%. Consumer products typically use niacinamide at 2–10% in an aqueous carrier. EVIK™ LyoPearl Niacinamide contains 12.8 mg of niacinamide per bead at 100% dry weight. Dissolution method and the volume of carrier used will determine the final application concentration. For reference: dissolving one bead (12.8 mg niacinamide) into 0.5 mL of water produces a 2.56% niacinamide solution; into 0.25 mL produces 5.12%. The large bead size (30 μL reconstituted volume) and high active content make this bead well-suited to concentrated single-dose treatment formats or to dissolution into a defined volume of carrier serum to achieve a target use concentration. Contact the Evik Diagnostics team to discuss dissolution protocol, target use concentration, and custom bead specifications if a different niacinamide content per bead is required.EVIK™ LyoPearl Niacinamide
EVIK™ LyoPearl Niacinamide is available for research and evaluation. Each bead contains 12.8 mg of niacinamide at 100% dry weight in a 30 μL bead. Supplied as 10 LyoPearls per vial.• → View product specifications, formula, and use instructions• → Request a sample or discuss formulation requirements [link to /contact]• → Custom lyobead formulation services at evikdiagnostics.com [link to https://www.evikdiagnostics.com]EVIK™ LyoPearl Niacinamide is part of the EVIK™ LyoPearl range of freeze-dried skincare lyobeads, developed by Evik Diagnostics — built on 15 years of freeze-dry bead expertise across diagnostics and life sciences.